Shaping the “hot” immunogenic tumor microenvironment by nanoparticles co‐delivering oncolytic peptide and <scp>TGF</scp> ‐β1 <scp>siRNA</scp> for boosting checkpoint blockade therapy-Reference-Cited by-同舟云学术

Shaping the “hot” immunogenic tumor microenvironment by nanoparticles co‐delivering oncolytic peptide and TGF ‐β1 siRNA for boosting checkpoint blockade therapy

Published:2022-08-11 Issue: Volume: Page:
ISSN:2380-6761
Container-title:Bioengineering & Translational Medicine
language:en
Short-container-title:Bioengineering & Transla Med

Author:

Phung Cao Dai¹,Nguyen Bao Loc¹,Jeong Jee‐Heon²,Chang Jae‐Hoon¹,Jin Sung Giu³,Choi Han‐Gon⁴,Ku Sae Kwang⁵,Kim Jong Oh¹^ORCID

Affiliation:

1. College of Pharmacy Yeungnam University Gyeongsan Republic of Korea

2. Department of Precision Medicine, School of Medicine Sungkyunkwan University Suwon Republic of Korea

3. Department of Pharmaceutical Engineering Dankook University Cheonan Republic of Korea

4. College of Pharmacy & Institute of Pharmaceutical Science and Technology Hanyang University Ansan Republic of Korea

5. College of Korean Medicine Daegu Haany University Gyeongsan Republic of Korea

Funder

National Research Foundation of Korea

Publisher

Wiley

Subject

Pharmaceutical Science,Biomedical Engineering,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/btm2.10392

Reference46 articles.

1. Rational combination immunotherapeutic approaches for effective cancer treatment

2. Anti-CTLA-4 antibody-functionalized dendritic cell-derived exosomes targeting tumor-draining lymph nodes for effective induction of antitumor T-cell responses

3. Reprogramming the T cell response to cancer by simultaneous, nanoparticle-mediated PD-L1 inhibition and immunogenic cell death

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Engineering nanomedicines for immunogenic eradication of cancer cells: Recent trends and synergistic approaches;Acta Pharmaceutica Sinica B;2024-06

2. Reigniting the cancer-immunity cycle with nanoparticles for simultaneous delivery of oncolytic peptides and a TLR agonist;Nano Today;2024-04

3. Advanced technologies for biomedical applications by emerging researchers in Asia‐Pacific;Bioengineering & Translational Medicine;2023-11

4. Liposomal co-delivery of toll-like receptors 3 and 7 agonists induce a hot triple-negative breast cancer immune environment;Journal of Controlled Release;2023-09

5. Thermosusceptible Nitric-Oxide-Releasing Nitrogel for Strengthening Antitumor Immune Responses with Tumor Collagen Diminution and Deep Tissue Delivery during NIR Laser-Assisted Photoimmunotherapy;ACS Applied Materials & Interfaces;2023-03-09